By Aderogba George The National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension. The announcement was made in a public alert No. 01/2025, released on the agency’s website Thursday. According to the alert, the decision was made due to the instability […]

The post NAFDAC discontinues registration of Artemether/Lumefantrine oral suspension appeared first on NewsDiaryOnline.